Meds Coupons

View Deals

8 Coupons

plemmons and co-authors disclosed no relevant relationships with industry. .

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
    .

    crispr therapeutics, mgh team up on new cancer treatments .